Another negative clinical trial of a new agent for the treatment of sepsis

This publication has 14 references indexed in Scilit:

• A second large controlled clinical study of E5, a monoclonal antibody to endotoxin
  Critical Care Medicine, 1995
• Recombinant endotoxin neutralizing protein improves survival from Escherichia coli sepsis in rats
  Critical Care Medicine, 1995
• SERUM LEVELS OF END PRODUCTS OF NITRIC OXIDE SYNTHESIS CORRELATE POSITIVELY WITH TUMOR NECROSIS FACTOR α AND NEGATIVELY WITH BODY TEMPERATURE IN PATIENTS WITH POSTOPERATIVE ABDOMINAL SEPSIS
  Shock, 1994
• Nosocomial Bloodstream Infection in Critically III Patients
  JAMA, 1994
• Protective effects of E5, an antiendotoxin monoclonal antibody, in the ovine pulmonary circulation
  Journal of Applied Physiology, 1993
• Efficacy of Anti-Endotoxin Monoclonal Antibody E5 Alone or in Combination with Ciprofloxacin in Neutropenic Rats with Pseudomonas Sepsis
  The Journal of Infectious Diseases, 1993
• Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide.
  The Journal of Experimental Medicine, 1993
• A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis
  JAMA, 1991
• Divergent Efficacy of Antibody to Tumor Necrosis Factor- in Intravascular and Peritonitis Models of Sepsis
  The Journal of Infectious Diseases, 1991
• Plasma Endotoxin as a Predictor of Multiple Organ Failure and Death in Systemic Meningococcal Disease
  The Journal of Infectious Diseases, 1989